The North American market for ureteral stents is expected to witness steady growth due to the high prevalence of urological disorders and the availability of advanced healthcare infrastructure in countries like the United States and Canada. The increasing adoption of minimally invasive procedures and the presence of key players in the region are also contributing to market growth.
Asia Pacific (China, Japan, South Korea):
The Asia Pacific market for ureteral stents is anticipated to experience significant growth owing to the rising prevalence of kidney and urinary tract diseases in countries such as China, Japan, and South Korea. Additionally, the increasing healthcare expenditure, growing awareness about urological disorders, and technological advancements in healthcare facilities are driving the demand for ureteral stents in the region.
Europe (United Kingdom, Germany, France):
In Europe, the market for ureteral stents is expected to witness substantial growth due to the high incidence of urinary stone diseases and the presence of a well-established healthcare system in countries like the United Kingdom, Germany, and France. The increasing geriatric population and the rising demand for minimally invasive urological procedures are also contributing to the market expansion in the region.